2024-514092-18-00招募中1 期
Oncolytic virus TILT-123 in combination with lymphocyte-depleting chemotherapy and TILs in the treatment of melanoma
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 9
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Trial Team
Scientific
TILT Biotherapeutics Oy
研究点 (1)
Loading locations...
相似试验
暂停
不适用
Intratumoral administration of oncolytic virus for unresectable pancreatic cancerPancreatic cancerjRCT207320000424
招募中
不适用
Oncolytic virus therapy using G47delta for patients with prostate cancerjRCTs03321060330
进行中（未招募）
1 期
Study of IPH4102 alone or in combination with chemotherapy in patients with Advanced T-cell Lymphoma.Advanced T-Cell Lymphomas (TCL), i.e. Cutaneous T Cell Lymphomas (CTCL) CTCL subtypes under investigation: relapsed/refractory Sézary Syndrome (SS), stage IB to IV Mycosis Fungoides (MF). AngioImmunoblastic T-cell Lymphoma (AITL), Anaplastic Large Cell Lymphoma (ALCL).MedDRA version: 20.0Level: HLTClassification code 10002450Term: Angioimmunoblastic T-cell lymphomasSystem Organ Class: 100000004851MedDRA version: 20.0Level: HLTClassification code 10002235Term: Anaplastic large cell lymphomas T- and null-cell typesSystem Organ Class: 100000004851MedDRA version: 20.0Level: HLTClassification code 10028484Term: Mycoses fungoidesSystem Organ Class: 100000004851EUCTR2018-003969-33-BEInnate Pharma SA170
进行中（未招募）
1 期
Study of IPH4102 alone or in combination with chemotherapy in patients with Advanced T-cell Lymphoma.Advanced T-Cell Lymphomas (TCL), i.e. Cutaneous T Cell Lymphomas (CTCL) CTCL subtypes under investigation: relapsed/refractory Sézary Syndrome (SS), stage IB to IV Mycosis Fungoides (MF).MedDRA version: 22.0Level: LLTClassification code: 10040522Term: Sezary's syndrome recurrent Class: 10029104MedDRA version: 22.0Level: LLTClassification code: 10040494Term: Sezary syndrome recurrent Class: 10029104MedDRA version: 22.0Level: LLTClassification code: 10028483Term: Mycosis fungoides Class: 10029104CTIS2023-507777-18-00Innate Pharma174
进行中（未招募）
1 期
Study of IPH4102 alone or in combination with chemotherapy in patients with Advanced T-cell Lymphoma.EUCTR2018-003969-33-ITINNATE PHARMA250